Status:
COMPLETED
Breathing Focused Yoga in Social Anxiety Disorder
Lead Sponsor:
Centre for Addiction and Mental Health
Conditions:
Social Anxiety Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this study is to determine the safety and effectiveness of Breathing Focused Yoga (BFY) in improving symptoms of social anxiety disorder (SAD). Patients with SAD will be randomized to 8 we...
Detailed Description
This is an exploratory 8-week study with a randomized controlled, parallel group design, and will be carried out in two phases: 1) 8-week treatment phase and 2) a 3-month follow-up phase. 60 patients...
Eligibility Criteria
Inclusion
- Male or female patients aged 18-65 years
- Primary diagnosis of SAD, per the DSM-IV-TR (APA, 2000)
- LSAS score of ≥50
- Absence of serious medical illness
- Not on any psychotropic medications currently, or on stable medications for at least 8 weeks prior to starting treatment
- Short-acting benzodiazepines (e.g. lorazepam 1 mg prn) and sleep medications (e.g. zopiclone 7.5 mg prn) may be used, but not within 12 hours prior to a study visit
Exclusion
- Current primary diagnosis of major depressive episode, mania or psychosis
- A score of ≥15 on the first 17 items of the HAM-D at Screening or Baseline
- Diagnosis of a substance abuse disorder within the prior 6 months
- Presence of medical or mental health conditions that would inhibit the patient's ability to participate in the study
- Currently receiving any structured formal psychotherapy (supportive therapy is allowed)
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02266680
Start Date
January 1 2012
End Date
January 30 2017
Last Update
July 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addition and Mental Health
Toronto, Ontario, Canada, M6J 1H4